X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (8) 8
index medicus (8) 8
infectious diseases (7) 7
hiv infections - drug therapy (6) 6
infectious disease (5) 5
adult (4) 4
antiretroviral drugs (4) 4
hiv (4) 4
hiv infection (4) 4
hiv infections - virology (4) 4
human immunodeficiency virus--hiv (4) 4
medical research (4) 4
resource-limited settings (4) 4
africa (3) 3
africa south of the sahara - epidemiology (3) 3
analysis (3) 3
anti-hiv agents - therapeutic use (3) 3
antiretroviral therapy, highly active (3) 3
antiviral agents (3) 3
article (3) 3
drug therapy (3) 3
efficacy (3) 3
female (3) 3
hiv infections - epidemiology (3) 3
immunology (3) 3
internal medicine (3) 3
male (3) 3
reverse transcriptase inhibitors - therapeutic use (3) 3
south-africa (3) 3
viral load (3) 3
aids/hiv (2) 2
anti-hiv agents - administration & dosage (2) 2
art (2) 2
care and treatment (2) 2
cd4 lymphocyte count (2) 2
clinical trials (2) 2
cohort studies (2) 2
dosage and administration (2) 2
drug therapy, combination (2) 2
drug-resistance (2) 2
health aspects (2) 2
high-dose fluconazole (2) 2
hiv infections - immunology (2) 2
hiv protease inhibitors - therapeutic use (2) 2
hiv-1 - drug effects (2) 2
hiv-infected patients (2) 2
infection (2) 2
non-inferiority trial (2) 2
patient outcomes (2) 2
predictors (2) 2
prevalence (2) 2
public health (2) 2
public, environmental & occupational health (2) 2
regimens (2) 2
resistance (2) 2
studies (2) 2
sub-saharan africa (2) 2
surveillance (2) 2
therapy (2) 2
treatment failure (2) 2
treatment outcome (2) 2
viral load - drug effects (2) 2
virological failure (2) 2
virus diseases (2) 2
2nd-line art (1) 1
acquired immune deficiency syndrome--aids (1) 1
acquired-immunodeficiency-syndrome (1) 1
active antiretroviral therapy (1) 1
adherence (1) 1
adolescent (1) 1
adults (1) 1
aids-related opportunistic infections - drug therapy (1) 1
aids-related opportunistic infections - epidemiology (1) 1
amphotericin-b (1) 1
anti-hiv agents - adverse effects (1) 1
anti-hiv agents - pharmacology (1) 1
anti-retroviral agents - classification (1) 1
anti-retroviral agents - therapeutic use (1) 1
antifungal agents - therapeutic use (1) 1
antiretroviral therapy (1) 1
antiretroviral therapy, highly active - statistics & numerical data (1) 1
antiretroviral-naive subjects (1) 1
blood-donors (1) 1
c reverse-transcriptase (1) 1
care (1) 1
cd4 cell count (1) 1
cd4 lymphocyte count - economics (1) 1
cohort (1) 1
coinfection - epidemiology (1) 1
combination (1) 1
confidence intervals (1) 1
cost-benefit analysis (1) 1
criteria (1) 1
cryptococcosis - diagnosis (1) 1
cryptococcosis - microbiology (1) 1
cryptococcosis - pathology (1) 1
cryptococcus - immunology (1) 1
cryptococcus - isolation & purification (1) 1
data collection (1) 1
developing countries (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet Global Health, ISSN 2214-109X, 2014, Volume 2, Issue 1, pp. e23 - e34
Summary Background New WHO guidelines recommend initiation of antiretroviral therapy for HIV-positive adults with CD4 counts of 500 cells per μL or less, a... 
Internal Medicine | HIV/AIDS | HIV PREVENTION | SOUTH-AFRICA | IMPACT | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | ART | SEX | RISK | INFECTION | PREVALENCE | SETTINGS
Journal Article
by Hakim, James G and Thompson, Jennifer and Kityo, Cissy and Hoppe, Anne and Kambugu, Andrew and van Oosterhout, Joep J and Lugemwa, Abbas and Siika, Abraham and Mwebaze, Raymond and Mweemba, Aggrey and Abongomera, George and Thomason, Margaret J and Easterbrook, Philippa and Mugyenyi, Peter and Walker, A Sarah and Paton, Nicholas I and Agweng, E and Awio, P and Bakeinyaga, G and Isabirye, C and Kabuga, U and Kasuswa, S and Katuramu, M and Kiweewa, F and Kyomugisha, H and Lutalo, E and Mulima, D and Musana, H and Musitwa, G and Musiime, V and Ndigendawan, M and Namata, H and Nkalubo, J and Labejja, P Ocitti and Okello, P and Olal, P and Pimundu, G and Segonga, P and Ssali, F and Tamale, Z and Tumukunde, D and Namala, W and Byaruhanga, R and Kayiwa, J and Tukamushaba, J and Abunyang, S and Eram, D and Denis, O and Lwalanda, R and Mugarura, L and Namusanje, J and Nankya, I and Nankya, A and Ndashimye, E and Nabulime, E and Senfuma, O and Bihabwa, G and Buluma, E and Elbireer, A and Kamya, D and Katwere, M and Kiggundu, R and Komujuni, C and Laker, E and Lubwama, E and Mambule, I and Matovu, J and Nakajubi, A and Nakku, J and Nalumenya, R and Namuyimbwa, L and Semitala, F and Wandera, B and Wanyama, J and Mugerwa, H and Ninsiima, E and Ssenkindu, T and Mwebe, S and Atwine, L and William, H and Katemba, C and Acaku, M and Ssebutinde, P and Kitizo, H and Kukundakwe, J and Naluguza, M and Ssegawa, K and Namayanja and Nsibuka, F and Tuhirirwe, P and Fortunate, M and Acen, J and Achidri, J and Amone, A and Amone, G and Chamai, M and Ditai, J and Kemigisa, M and Kiconco, M and Matama, C and ... and Europe Africa Res Network and Europe Africa Research Network for Evaluation of Second-line Therapy (EARNEST) Trial Team
The Lancet Infectious Diseases, ISSN 1473-3099, 01/2018, Volume 18, Issue 1, pp. 47 - 57
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2010, Volume 10, Issue 11, pp. 791 - 802
Journal Article
Journal Article
Lancet, The, ISSN 0140-6736, 2007, Volume 370, Issue 9603, pp. 1923 - 1928
Journal Article
Lancet HIV, The, ISSN 2352-3018, 2017, Volume 4, Issue 8, pp. e341 - e348
Journal Article
Lancet HIV, The, ISSN 2352-3018, 2015, Volume 2, Issue 7, pp. e271 - e278
Journal Article